Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Timber Pharmaceuticals, Inc. | tm2116567d1_ex31-2.htm |
| 10-K/A - FORM 10-K/A - Timber Pharmaceuticals, Inc. | tm2116567d1_10ka.htm |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John Koconis, certify that:
| 1. | I have reviewed this report on Form 10-K/A (Amendment No. 1) of Timber Pharmaceuticals, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| /s/ John Koconis | |
| John Koconis | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
| May 17, 2021 |